Press release content from Business Wire. The AP news staff was not involved in its creation.
Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland
April 15, 2021 GMT
TURKU, Finland (BUSINESS WIRE) Apr 15, 2021
Medicortex Finland Oy, a biotechnology company developing a breakthrough biomarker-based diagnostic kit for brain injury detection, completed collection of body fluid samples in its third large clinical study. Children and adolescents were recruited who visited the hospital with a suspected mild traumatic brain injury or concussion.
“Collecting the samples in this large clinical trial is a significant achievement for Medicortex, and represents an important step forward in the development of the ProbTBI TM, a diagnostic kit for early detection of head injury” said Dr. Adrian Harel, Chief Executive Officer of Medicortex Finland. “Brain injury is a devastating condition leading to medical complications if not diagnosed. We have the o
Business Finland Awarded Funding for Medicortex
Medicortex Finland Oy, a Finnish biotechnology company focusing on brain injury diagnostics and drug development, announces receiving funding from the Finnish government innovation funding branch Business Finland. The funds are meant to expedite the development of a medical diagnostic test to improve detection of traumatic brain injury (TBI) and concussion.
Medicortex has discovered novel biomarkers of head injury in body fluids such as saliva and urine. The funding which covers 50% of the expenses will support a project consisting of the development of a test kit for easy and rapid detection of brain injury and concussion. The objective of the company s biomarker program is to generate new means for early detection of brain injury, which is a global unresolved issue. Current methods of brain injury diagnostics which are based on neurological examination and imaging do not reliably detect mild injury, yet they can have implications t